Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: GLP-1RA, SGLT2i Sep 25 | 2020New Semaglutide HFpEF Trial (STEP HFpEF); DAPA-MI Posted on CT.gov; Final Day of EASD 2020 (Sept 25)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Sep 24 | 2020Dexcom Partners with UVA, Novo CVD Real-world Treatment Study, Movano Partners for Smartwatch CGM; Imeglimin Ph3 Data; EASD 2020 Key Press Releases (Sept 24)Purchase Blast
$599
Posted in: GLP-1RA, Other Sep 23 | 2020FDA Launches Digital Health Center of Excellence; Novo Initiates New Ozempic and Rybelsus Trials; vTv Presents TTP399 Data; EASD 2020 Key Press Releases (Sept 23)Purchase Blast
$599
Posted in: Autologous, BCMA Sep 22 | 2020BMS and bluebird bio Receive Priority Review for Ide-cel; PDUFA Projected Around March 27, 2021Purchase Blast$599
Posted in: Basal Insulin, GLP-1RA, Glucose Monitoring Sep 22 | 2020New Novo QW Insulin Icodec Data; Novo Updates Rybelsus Website; Dexcom G6 VA Pharmacy Distribution; Ascensia Partners to Accelerate Data Strategy; REWIND Canada Approval; Oramed ORMD-0801 NASH Data; EASD 2020 Key Press Releases (Sept 22)Purchase Blast$599
Posted in: Glucose Monitoring, Insulin Delivery Sep 21 | 2020Insulet Expands DASH Availability in Europe; Nemaura In-Licenses Healthimation Diabetes App; Dario Enters Distribution Agreement with HMC; Arecor uRAI to be Presented Tomorrow; Adocia to Host Business Review; EASD 2020 Key Press Releases (Sept 21)Purchase Blast
$599
Posted in: Autologous, CD19, CD22 Sep 21 | 2020Updated AUTO3 Ph1/2 ALEXANDER Results; ESMO 2020 Investor Call SummaryPurchase Blast
$599
Posted in: Glucose Monitoring Sep 18 | 2020Medtronic Recalls Guardian Connect App After Data Upload DisruptionsPurchase Blast
$599
Posted in: Other Sep 18 | 2020Diamyd to Move Forward with Ph3 Trial in HLA-Present T1DM Subpopulation; Additional Results from DIAGNODE-2Purchase Blast
$599
Posted in: CAR-T, CD123, CD22, CS1 Sep 18 | 2020Thoughts on Cellectis’s CAR-T Program; Potential UCARTCS1 Protocol Changes; Q2 2020 Earnings CallPurchase Blast
$599
Posted in: Glucose Monitoring Sep 17 | 2020Abbott to Launch the First "Glucose Sport Biosensor"Purchase Blast
$599
Posted in: Glucose Monitoring, Other Sep 17 | 2020Dexcom Announces New CGM Registry and Global Business Service Site in Lithuania; Dario Appoints Former LifeScan Exec to Scientific Advisory BoardPurchase Blast
$599
Posted in: Other Sep 16 | 2020Japanese NDA Submitted for Imeglimin; Poxel H1 '20 Earnings UpdatePurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery, Other, SGLT2i Sep 16 | 2020Apple Cites T1DM Omnipod Patient Story at Tuesday Event; Jardiance Post-MI Trial (EMPACT-MI) Receives FDA FTD; Adocia Topline Results from M1Pram Ph1b Trial Extension; Welldoc/UMD Employs AI to Identify Digital Health Habits; Oramed’s Positive Diabetes Market Survey Results; Diamyd Receives $13.9M Towards Companion Medical SharesPurchase Blast
$599
Posted in: Glucose Monitoring Sep 15 | 2020Senseonics Hosts Investor Event with Special Guest AscensiaPurchase Blast
$599
Posted in: Glucose Monitoring, Other Sep 14 | 2020Diamyd's Ph2b DIAGNODE-2 Trial Topline Results; New MicroTech Medical BGM 510(k) Clearance; Voluntis Announces €2M in FundingPurchase Blast
$599
Posted in: GLP-1RA, Glucagon, SGLT2i Sep 14 | 2020High-dose Trulicity, DAPA-HF and Gvoke up for Opinions; CHMP Agenda September 14-17Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other Sep 11 | 2020Thoughts on Newly Permanent Lilly Insulin+Baqsimi Copay Cards; New Novo+ACC ASCVD Registry; ProSciento Receives VC InvestmentPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, GLP-1RA Sep 10 | 2020New Tirzepatide + Glargine U100 vs. Basal-Bolus Trial (SURPASS-6)Purchase Blast
$599
Posted in: Autologous, BCMA, CAR-T, CD19, CD22 Sep 08 | 2020Thoughts on Autolus's CAR-T Program; Q2 2020 Earnings CallPurchase BlastGet the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
